25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AbbVie Inc
Buy, Hold or Sell?

Let's analyze Abbvie together

I guess you are interested in AbbVie Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AbbVie Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AbbVie Inc

I send you an email if I find something interesting about AbbVie Inc.

1. Quick Overview

1.1. Quick analysis of Abbvie (30 sec.)










1.2. What can you expect buying and holding a share of Abbvie? (30 sec.)

How much money do you get?

How much money do you get?
$6.15
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$3.43
Expected worth in 1 year
$0.00
How sure are you?
77.5%

+ What do you gain per year?

Total Gains per Share
$2.73
Return On Investment
1.4%

For what price can you sell your share?

Current Price per Share
$192.87
Expected price per share
$168.06 - $201.97
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Abbvie (5 min.)




Live pricePrice per Share (EOD)
$192.87
Intrinsic Value Per Share
$-4.53 - $134.97
Total Value Per Share
$-1.10 - $138.40

2.2. Growth of Abbvie (5 min.)




Is Abbvie growing?

Current yearPrevious yearGrowGrow %
How rich?$6b$13.9b-$6b-77.5%

How much money is Abbvie making?

Current yearPrevious yearGrowGrow %
Making money$1.2b$1.6b-$348m-27.2%
Net Profit Margin9.3%11.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Abbvie (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Abbvie?

Welcome investor! Abbvie's management wants to use your money to grow the business. In return you get a share of Abbvie.

First you should know what it really means to hold a share of Abbvie. And how you can make/lose money.

Speculation

The Price per Share of Abbvie is $192.87. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abbvie.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abbvie, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.43. Based on the TTM, the Book Value Change Per Share is $-0.86 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $1.54 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abbvie.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.880.5%0.720.4%0.920.5%1.130.6%0.940.5%
Usd Book Value Change Per Share-0.43-0.2%-0.86-0.4%-0.54-0.3%0.400.2%0.020.0%
Usd Dividend Per Share1.550.8%1.540.8%1.470.8%1.340.7%0.980.5%
Usd Total Gains Per Share1.130.6%0.680.4%0.920.5%1.740.9%1.000.5%
Usd Price Per Share197.48-176.52-151.19-134.11-103.95-
Price to Earnings Ratio56.04-63.49-97.98-108.39-81.81-
Price-to-Total Gains Ratio175.22-364.69-26.83-66.07-13.50-
Price to Book Ratio57.64-42.18-19.54-17.84-15.56-
Price-to-Total Gains Ratio175.22-364.69-26.83-66.07-13.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share192.87
Number of shares5
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.541.34
Usd Book Value Change Per Share-0.860.40
Usd Total Gains Per Share0.681.74
Gains per Quarter (5 shares)3.418.70
Gains per Year (5 shares)13.6434.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
131-17427825
262-3418531660
392-5132802495
4123-684610732130
5154-866013440165
6185-1037416048200
7215-1208818757235
8246-13710221465270
9277-15411624173305
10308-17113026781340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%37.03.00.092.5%53.03.00.094.6%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%10.010.00.050.0%20.020.00.050.0%27.026.03.048.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%47.00.09.083.9%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%31.09.00.077.5%40.013.03.071.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AbbVie Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.425-0.856+101%-0.544+28%0.404-205%0.020-2234%
Book Value Per Share--3.4264.421-23%7.836-56%6.106-44%3.418+0%
Current Ratio--0.6450.815-21%0.944-32%1.107-42%1.248-48%
Debt To Asset Ratio--0.9580.945+1%0.898+7%0.928+3%0.953+0%
Debt To Equity Ratio--22.77018.073+26%8.989+153%10.018+127%9.302+145%
Dividend Per Share--1.5521.538+1%1.468+6%1.337+16%0.982+58%
Enterprise Value--219868560000.000191221405000.000+15%155415697500.000+41%123624690949.344+78%102299208873.968+115%
Eps--0.8810.723+22%0.917-4%1.126-22%0.936-6%
Ev To Ebitda Ratio--11.1438.169+36%8.653+29%6.412+74%3.366+231%
Ev To Sales Ratio--3.8013.465+10%2.836+34%2.333+63%2.632+44%
Free Cash Flow Per Share--2.9332.204+33%3.485-16%2.797+5%2.031+44%
Free Cash Flow To Equity Per Share--1.2001.808-34%0.330+264%1.553-23%1.029+17%
Gross Profit Margin--1.0000.331+202%0.798+25%0.826+21%0.913+10%
Intrinsic Value_10Y_max--134.975--------
Intrinsic Value_10Y_min---4.528--------
Intrinsic Value_1Y_max--11.978--------
Intrinsic Value_1Y_min--6.711--------
Intrinsic Value_3Y_max--37.169--------
Intrinsic Value_3Y_min--14.078--------
Intrinsic Value_5Y_max--63.781--------
Intrinsic Value_5Y_min--14.718--------
Market Cap340828285628.160-3%349934560000.000312791655000.000+12%268243947500.000+30%237919840949.344+47%184162083873.968+90%
Net Profit Margin--0.1080.093+16%0.114-5%0.155-30%0.172-37%
Operating Margin--0.1970.286-31%0.353-44%0.380-48%0.344-43%
Operating Ratio--0.7350.707+4%0.717+3%0.692+6%0.692+6%
Pb Ratio56.295-2%57.64042.177+37%19.541+195%17.837+223%15.558+270%
Pe Ratio54.735-2%56.04363.488-12%97.984-43%108.392-48%81.806-31%
Price Per Share192.870-2%197.480176.518+12%151.193+31%134.105+47%103.950+90%
Price To Free Cash Flow Ratio16.437-2%16.83022.579-25%11.563+46%13.356+26%12.651+33%
Price To Total Gains Ratio171.127-2%175.217364.690-52%26.829+553%66.068+165%13.500+1198%
Quick Ratio--0.4360.597-27%0.673-35%0.864-50%0.990-56%
Return On Assets--0.0110.009+21%0.012-9%0.015-28%0.018-41%
Return On Equity--0.2590.178+46%0.116+122%0.134+93%0.167+55%
Total Gains Per Share--1.1270.682+65%0.924+22%1.741-35%1.002+13%
Usd Book Value--6071000000.0007834000000.000-23%13904250000.000-56%10842650000.000-44%6066400000.000+0%
Usd Book Value Change Per Share---0.425-0.856+101%-0.544+28%0.404-205%0.020-2234%
Usd Book Value Per Share--3.4264.421-23%7.836-56%6.106-44%3.418+0%
Usd Dividend Per Share--1.5521.538+1%1.468+6%1.337+16%0.982+58%
Usd Enterprise Value--219868560000.000191221405000.000+15%155415697500.000+41%123624690949.344+78%102299208873.968+115%
Usd Eps--0.8810.723+22%0.917-4%1.126-22%0.936-6%
Usd Free Cash Flow--5198000000.0003905750000.000+33%6182250000.000-16%4963850000.000+5%3599775000.000+44%
Usd Free Cash Flow Per Share--2.9332.204+33%3.485-16%2.797+5%2.031+44%
Usd Free Cash Flow To Equity Per Share--1.2001.808-34%0.330+264%1.553-23%1.029+17%
Usd Market Cap340828285628.160-3%349934560000.000312791655000.000+12%268243947500.000+30%237919840949.344+47%184162083873.968+90%
Usd Price Per Share192.870-2%197.480176.518+12%151.193+31%134.105+47%103.950+90%
Usd Profit--1561000000.0001280500000.000+22%1628500000.000-4%1998000000.000-22%1658100000.000-6%
Usd Revenue--14460000000.00013883250000.000+4%13784500000.000+5%13215450000.000+9%10094725000.000+43%
Usd Total Gains Per Share--1.1270.682+65%0.924+22%1.741-35%1.002+13%
 EOD+4 -4MRQTTM+26 -14YOY+20 -205Y+17 -2310Y+24 -16

3.3 Fundamental Score

Let's check the fundamental score of AbbVie Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1554.735
Price to Book Ratio (EOD)Between0-156.295
Net Profit Margin (MRQ)Greater than00.108
Operating Margin (MRQ)Greater than00.197
Quick Ratio (MRQ)Greater than10.436
Current Ratio (MRQ)Greater than10.645
Debt to Asset Ratio (MRQ)Less than10.958
Debt to Equity Ratio (MRQ)Less than122.770
Return on Equity (MRQ)Greater than0.150.259
Return on Assets (MRQ)Greater than0.050.011
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of AbbVie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.785
Ma 20Greater thanMa 50182.888
Ma 50Greater thanMa 100178.984
Ma 100Greater thanMa 200183.050
OpenGreater thanClose193.950
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About AbbVie Inc

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; AbCellera Biologics Inc.; and Tentarix Biotherapeutics, LP. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Fundamental data was last updated by Penke on 2025-02-06 09:36:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Abbvie earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Abbvie to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 10.8% means that $0.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AbbVie Inc:

  • The MRQ is 10.8%. The company is making a huge profit. +2
  • The TTM is 9.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ10.8%TTM9.3%+1.5%
TTM9.3%YOY11.4%-2.1%
TTM9.3%5Y15.5%-6.2%
5Y15.5%10Y17.2%-1.7%
4.3.1.2. Return on Assets

Shows how efficient Abbvie is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abbvie to the Drug Manufacturers - General industry mean.
  • 1.1% Return on Assets means that Abbvie generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AbbVie Inc:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM0.9%+0.2%
TTM0.9%YOY1.2%-0.3%
TTM0.9%5Y1.5%-0.6%
5Y1.5%10Y1.8%-0.3%
4.3.1.3. Return on Equity

Shows how efficient Abbvie is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abbvie to the Drug Manufacturers - General industry mean.
  • 25.9% Return on Equity means Abbvie generated $0.26 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AbbVie Inc:

  • The MRQ is 25.9%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 17.8%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ25.9%TTM17.8%+8.1%
TTM17.8%YOY11.6%+6.1%
TTM17.8%5Y13.4%+4.4%
5Y13.4%10Y16.7%-3.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AbbVie Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Abbvie is operating .

  • Measures how much profit Abbvie makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abbvie to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 19.7% means the company generated $0.20  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AbbVie Inc:

  • The MRQ is 19.7%. The company is operating efficient. +1
  • The TTM is 28.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ19.7%TTM28.6%-8.9%
TTM28.6%YOY35.3%-6.7%
TTM28.6%5Y38.0%-9.4%
5Y38.0%10Y34.4%+3.6%
4.3.2.2. Operating Ratio

Measures how efficient Abbvie is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.74 means that the operating costs are $0.74 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AbbVie Inc:

  • The MRQ is 0.735. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.707. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.735TTM0.707+0.028
TTM0.707YOY0.717-0.010
TTM0.7075Y0.692+0.014
5Y0.69210Y0.692+0.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AbbVie Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Abbvie is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 0.65 means the company has $0.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AbbVie Inc:

  • The MRQ is 0.645. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.815. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.645TTM0.815-0.170
TTM0.815YOY0.944-0.128
TTM0.8155Y1.107-0.292
5Y1.10710Y1.248-0.141
4.4.3.2. Quick Ratio

Measures if Abbvie is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abbvie to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.44 means the company can pay off $0.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AbbVie Inc:

  • The MRQ is 0.436. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.597. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.436TTM0.597-0.161
TTM0.597YOY0.673-0.077
TTM0.5975Y0.864-0.267
5Y0.86410Y0.990-0.126
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AbbVie Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Abbvie assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abbvie to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.96 means that Abbvie assets are financed with 95.8% credit (debt) and the remaining percentage (100% - 95.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AbbVie Inc:

  • The MRQ is 0.958. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.945. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.958TTM0.945+0.013
TTM0.945YOY0.898+0.047
TTM0.9455Y0.928+0.017
5Y0.92810Y0.953-0.025
4.5.4.2. Debt to Equity Ratio

Measures if Abbvie is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abbvie to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 2,277.0% means that company has $22.77 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AbbVie Inc:

  • The MRQ is 22.770. The company is unable to pay all its debts with equity. -1
  • The TTM is 18.073. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ22.770TTM18.073+4.697
TTM18.073YOY8.989+9.084
TTM18.0735Y10.018+8.055
5Y10.01810Y9.302+0.715
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Abbvie generates.

  • Above 15 is considered overpriced but always compare Abbvie to the Drug Manufacturers - General industry mean.
  • A PE ratio of 56.04 means the investor is paying $56.04 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AbbVie Inc:

  • The EOD is 54.735. Based on the earnings, the company is expensive. -2
  • The MRQ is 56.043. Based on the earnings, the company is expensive. -2
  • The TTM is 63.488. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD54.735MRQ56.043-1.308
MRQ56.043TTM63.488-7.445
TTM63.488YOY97.984-34.496
TTM63.4885Y108.392-44.904
5Y108.39210Y81.806+26.587
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AbbVie Inc:

  • The EOD is 16.437. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 16.830. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 22.579. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD16.437MRQ16.830-0.393
MRQ16.830TTM22.579-5.749
TTM22.579YOY11.563+11.015
TTM22.5795Y13.356+9.222
5Y13.35610Y12.651+0.705
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Abbvie is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 57.64 means the investor is paying $57.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AbbVie Inc:

  • The EOD is 56.295. Based on the equity, the company is expensive. -2
  • The MRQ is 57.640. Based on the equity, the company is expensive. -2
  • The TTM is 42.177. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD56.295MRQ57.640-1.346
MRQ57.640TTM42.177+15.463
TTM42.177YOY19.541+22.636
TTM42.1775Y17.837+24.340
5Y17.83710Y15.558+2.279
4.6.2. Total Gains per Share

2.4. Latest News of AbbVie Inc

Does AbbVie Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from AbbVie Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-02-16
14:16
AbbVie Full Year 2024 Earnings: EPS Misses ExpectationsRead
2025-02-15
10:55
Is AbbVie Stock a Buy Now?Read
2025-02-14
13:03
John Rogers' Strategic Moves: A Closer Look at Royal Caribbean Group's ImpactRead
2025-02-13
17:57
AbbVie Declares Quarterly DividendRead
2025-02-13
16:48
AbbVie Inc. (ABBV): Among Lee Munder Capital Group’s Top Stock PicksRead
2025-02-13
15:00
Is AbbVie Inc. (NYSE:ABBV) Trading At A 47% Discount?Read
2025-02-11
21:20
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs WarnsRead
2025-02-09
20:30
3 Fabulous Dividend Stocks to Buy in FebruaryRead
2025-02-09
17:15
68-Year-Old Earning $4,300/Month in Dividends Shares His Top 7 Stock Picks — 'Dividends Have Been Consistent, Stable'Read
2025-02-09
14:04
Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look ForRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of AbbVie Inc.

4.8.1. Institutions holding AbbVie Inc

Institutions are holding 73.453% of the shares of AbbVie Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Vanguard Group Inc9.71330.6071716478419882950.5791
2024-09-30BlackRock Inc7.69450.5637135972567-458943-0.3364
2024-09-30JPMorgan Chase & Co5.90920.7847104424202-2691628-2.5128
2024-09-30State Street Corp4.47430.63547906793512676851.6294
2024-09-30Morgan Stanley - Brokerage Accounts2.19090.554338716851-35770505-48.0223
2024-09-30Capital Research & Mgmt Co - Division 32.08181.394336787844-1814340-4.7001
2024-09-30Geode Capital Management, LLC2.04630.576236161045-520705-1.4195
2024-09-30Capital Research Global Investors1.87911.362933205581201870.0608
2024-09-30Charles Schwab Investment Management Inc1.34890.898423836797-1137780-4.5558
2024-09-30Bank of America Corp1.1850.3433209406633009071.4579
2024-09-30Northern Trust Corp1.10490.631219524981-759111-3.7424
2024-09-30Bank of New York Mellon Corp0.96570.626717065573-463281-2.643
2024-09-30Capital World Investors0.87440.47315451035516745650.2496
2024-09-30Legal & General Group PLC0.8590.624715179224-98256-0.6431
2024-09-30Franklin Resources Inc0.78510.765713873744-2080791-13.042
2024-09-30Ameriprise Financial Inc0.78320.701113840108-209515-1.4912
2024-09-30FMR Inc0.77130.1638136304045114703.8987
2024-09-30UBS Group AG USD0.65040.494511494106-383411-3.228
2024-09-30UBS Group AG USD0.65040.494511494106-383411-3.228
Total 45.967712.6954812314607-38515677-4.7%

4.9.2. Funds holding AbbVie Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Vanguard Total Stock Mkt Idx Inv3.13510.55355401617-121464-0.2188
2024-12-31Vanguard Institutional 500 Index Trust2.70810.6301478558223638320.7661
2024-12-31Fidelity 500 Index1.24140.6293219365501100840.5044
2025-01-30SPDR® S&P 500® ETF Trust1.23140.601521760992-1039-0.0048
2025-01-29iShares Core S&P 500 ETF1.16740.603820629854-35428-0.1714
2024-12-31Capital Group American Mutual Comp1.01983.161718021744-1310382-6.7783
2024-12-31American Funds American Mutual A1.01983.161718021744-1310382-6.7783
2025-01-30Schwab US Dividend Equity ETF™0.89274.070515774973113750.0722
2024-12-31Vanguard Value Index Inv0.8521.458915055974-53709-0.3555
2024-12-31Capital Group Wash Mutual Invtrs Comp0.75161.246113281570-2174789-14.0705
2024-12-31American Funds Washington Mutual A0.75161.246113281570-2174789-14.0705
2025-01-30The Health Care Select Sector SPDR® ETF0.72925.770712885235581280.4532
2024-12-31American Funds Capital Income Bldr A0.68712.043312142305-1486044-10.9041
2024-12-31Vanguard Institutional Index I0.63110.629611152555-28377-0.2538
2024-12-31Vanguard Dividend Appreciation ETF0.55191.682897535271424241.4819
2024-12-31State St S&P 500® Indx SL Cl III0.48030.62478487648-70973-0.8293
2024-12-31American Funds Invmt Co of Amer A0.44760.91587909048-352803-4.2703
2024-12-31Capital Group Investment Co of Amer Comp0.44760.91587909048-352803-4.2703
2024-12-31Vanguard High Dividend Yield ETF0.41911.79287406813955891.3074
2024-12-31Blackrock Eq Idx Fund CF0.37510.62696627823-59183-0.885
Total 19.539932.3651345296412-8750733-2.5%

5.3. Insider Transactions

Insiders are holding 0.096% of the shares of AbbVie Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-12-16Kevin K BuckbeeSELL1800172.24
2024-08-05Richard A GonzalezSELL66500186.52
2024-07-17Richard A GonzalezSELL282845175
2024-03-20Nicholas DonoghoeSELL21082176.3
2024-03-18Jeffrey Ryan StewartSELL58949178.79
2024-02-29Kevin K BuckbeeSELL5144176.65
2024-02-29Perry C SiatisSELL9891177.39
2024-02-29Robert A MichaelSELL68879176.45
2024-02-28Richard A GonzalezSELL138616177.27
2024-02-23Perry C SiatisSELL13753177.51
2024-02-23Scott T ReentsSELL14140177.44
2024-02-21Azita Saleki-gerhardtSELL52870173.71
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets143,422,000
Total Liabilities137,351,000
Total Stockholder Equity6,032,000
 As reported
Total Liabilities 137,351,000
Total Stockholder Equity+ 6,032,000
Total Assets = 143,422,000

Assets

Total Assets143,422,000
Total Current Assets27,785,000
Long-term Assets115,637,000
Total Current Assets
Cash And Cash Equivalents 7,257,000
Short-term Investments 28,000
Net Receivables 11,472,000
Inventory 4,450,000
Other Current Assets 4,578,000
Total Current Assets  (as reported)27,785,000
Total Current Assets  (calculated)27,785,000
+/-0
Long-term Assets
Property Plant Equipment 5,141,000
Goodwill 35,295,000
Long Term Investments 267,000
Intangible Assets 66,646,000
Long-term Assets Other 8,288,000
Long-term Assets  (as reported)115,637,000
Long-term Assets  (calculated)115,637,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities43,062,000
Long-term Liabilities94,289,000
Total Stockholder Equity6,032,000
Total Current Liabilities
Short-term Debt 12,570,000
Short Long Term Debt 12,570,000
Accounts payable 30,398,000
Other Current Liabilities 30,492,000
Total Current Liabilities  (as reported)43,062,000
Total Current Liabilities  (calculated)86,030,000
+/- 42,968,000
Long-term Liabilities
Long term Debt 58,509,000
Long-term Liabilities Other 33,031,000
Long-term Liabilities  (as reported)94,289,000
Long-term Liabilities  (calculated)91,540,000
+/- 2,749,000
Total Stockholder Equity
Common Stock18,000
Retained Earnings -4,964,000
Accumulated Other Comprehensive Income -2,334,000
Other Stockholders Equity 13,312,000
Total Stockholder Equity (as reported)6,032,000
Total Stockholder Equity (calculated)6,032,000
+/-0
Other
Capital Stock18,000
Cash and Short Term Investments 7,285,000
Common Stock Shares Outstanding 1,772,000
Current Deferred Revenue-30,398,000
Liabilities and Stockholders Equity 143,422,000
Net Debt 63,822,000
Net Invested Capital 77,111,000
Net Working Capital -15,277,000
Property Plant and Equipment Gross 12,279,000
Short Long Term Debt Total 71,079,000



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-31
> Total Assets 
21,134,705
0
0
0
19,657,166
18,961,563
17,709,554
22,729,979
27,008,000
27,169,000
27,910,000
28,252,000
29,198,000
28,657,000
29,045,000
28,454,000
27,547,000
26,699,000
53,855,000
54,832,000
53,050,000
53,720,000
67,211,000
66,626,000
66,099,000
65,664,000
66,994,000
68,840,000
70,786,000
69,342,000
61,641,000
66,164,000
59,352,000
56,769,000
57,142,000
59,441,000
89,115,000
91,199,000
149,530,000
149,621,000
150,565,000
150,501,000
147,972,000
148,858,000
146,529,000
143,211,000
143,186,000
141,325,000
138,805,000
134,544,000
135,367,000
136,221,000
134,711,000
148,874,000
141,937,000
143,422,000
143,422,000141,937,000148,874,000134,711,000136,221,000135,367,000134,544,000138,805,000141,325,000143,186,000143,211,000146,529,000148,858,000147,972,000150,501,000150,565,000149,621,000149,530,00091,199,00089,115,00059,441,00057,142,00056,769,00059,352,00066,164,00061,641,00069,342,00070,786,00068,840,00066,994,00065,664,00066,099,00066,626,00067,211,00053,720,00053,050,00054,832,00053,855,00026,699,00027,547,00028,454,00029,045,00028,657,00029,198,00028,252,00027,910,00027,169,00027,008,00022,729,97917,709,55418,961,56319,657,16600021,134,705
   > Total Current Assets 
0
0
0
0
7,354,155
6,751,048
5,992,960
10,930,739
15,354,000
14,923,000
15,662,000
16,543,000
17,848,000
17,329,000
17,794,000
17,555,000
16,088,000
15,408,000
16,877,000
17,912,000
16,314,000
16,622,000
16,791,000
16,290,000
16,187,000
15,547,000
16,962,000
18,930,000
21,223,000
20,444,000
13,845,000
18,465,000
16,945,000
14,413,000
15,100,000
20,166,000
49,519,000
51,758,000
21,256,000
23,009,000
24,173,000
26,569,000
25,999,000
28,957,000
27,928,000
26,509,000
29,100,000
30,364,000
28,463,000
26,488,000
28,852,000
33,224,000
33,002,000
38,871,000
33,816,000
27,785,000
27,785,00033,816,00038,871,00033,002,00033,224,00028,852,00026,488,00028,463,00030,364,00029,100,00026,509,00027,928,00028,957,00025,999,00026,569,00024,173,00023,009,00021,256,00051,758,00049,519,00020,166,00015,100,00014,413,00016,945,00018,465,00013,845,00020,444,00021,223,00018,930,00016,962,00015,547,00016,187,00016,290,00016,791,00016,622,00016,314,00017,912,00016,877,00015,408,00016,088,00017,555,00017,794,00017,329,00017,848,00016,543,00015,662,00014,923,00015,354,00010,930,7395,992,9606,751,0487,354,1550000
       Cash And Cash Equivalents 
9,644
0
0
0
27,482
40,999
74,537
2,760,988
5,901,000
6,979,000
8,743,000
8,975,000
9,595,000
8,140,000
9,086,000
7,719,000
8,348,000
7,906,000
7,400,000
9,223,000
8,399,000
7,556,000
6,327,000
6,218,000
5,100,000
4,740,000
6,088,000
8,446,000
9,303,000
9,007,000
3,547,000
8,015,000
7,289,000
4,897,000
5,172,000
10,648,000
39,924,000
41,142,000
6,017,000
7,890,000
8,449,000
9,755,000
8,546,000
12,182,000
9,746,000
6,098,000
8,521,000
11,832,000
9,201,000
6,711,000
8,759,000
13,287,000
12,814,000
18,067,000
13,130,000
7,257,000
7,257,00013,130,00018,067,00012,814,00013,287,0008,759,0006,711,0009,201,00011,832,0008,521,0006,098,0009,746,00012,182,0008,546,0009,755,0008,449,0007,890,0006,017,00041,142,00039,924,00010,648,0005,172,0004,897,0007,289,0008,015,0003,547,0009,007,0009,303,0008,446,0006,088,0004,740,0005,100,0006,218,0006,327,0007,556,0008,399,0009,223,0007,400,0007,906,0008,348,0007,719,0009,086,0008,140,0009,595,0008,975,0008,743,0006,979,0005,901,0002,760,98874,53740,99927,4820009,644
       Short-term Investments 
1,873,621
0
0
0
626,099
1,992
0
1,824,617
2,075,000
500,000
11,000
621,000
300,000
960,000
1,160,000
9,000
26,000
18,000
879,000
26,000
8,000
1,044,000
1,675,000
1,732,000
1,323,000
1,508,000
1,117,000
1,108,000
486,000
467,000
196,000
770,000
772,000
331,000
244,000
0
0
0
23,000
60,000
30,000
22,000
54,000
67,000
84,000
1,474,000
1,440,000
47,000
28,000
11,000
7,000
3,000
2,000
2,000
27,000
28,000
28,00027,0002,0002,0003,0007,00011,00028,00047,0001,440,0001,474,00084,00067,00054,00022,00030,00060,00023,000000244,000331,000772,000770,000196,000467,000486,0001,108,0001,117,0001,508,0001,323,0001,732,0001,675,0001,044,0008,00026,000879,00018,00026,0009,0001,160,000960,000300,000621,00011,000500,0002,075,0001,824,61701,992626,0990001,873,621
       Net Receivables 
0
0
0
0
3,817,486
3,646,763
2,994,005
3,097,510
4,298,000
4,299,000
3,755,000
3,798,000
4,803,000
4,590,000
3,811,000
3,995,000
4,291,000
4,356,000
4,367,000
4,574,000
4,730,000
4,753,000
5,048,000
4,999,000
4,758,000
4,677,000
4,859,000
4,891,000
5,088,000
5,841,000
5,793,000
5,780,000
5,384,000
5,680,000
5,482,000
5,529,000
5,428,000
6,362,000
8,354,000
8,416,000
8,822,000
9,588,000
9,914,000
9,281,000
9,977,000
10,733,000
11,237,000
10,743,000
11,254,000
11,473,000
11,491,000
11,412,000
11,155,000
11,949,000
11,724,000
11,472,000
11,472,00011,724,00011,949,00011,155,00011,412,00011,491,00011,473,00011,254,00010,743,00011,237,00010,733,0009,977,0009,281,0009,914,0009,588,0008,822,0008,416,0008,354,0006,362,0005,428,0005,529,0005,482,0005,680,0005,384,0005,780,0005,793,0005,841,0005,088,0004,891,0004,859,0004,677,0004,758,0004,999,0005,048,0004,753,0004,730,0004,574,0004,367,0004,356,0004,291,0003,995,0003,811,0004,590,0004,803,0003,798,0003,755,0004,299,0004,298,0003,097,5102,994,0053,646,7633,817,4860000
       Inventory 
836,270
0
0
0
871,582
915,794
862,775
958,878
1,091,000
1,037,000
1,085,000
1,172,000
1,150,000
1,104,000
1,048,000
1,008,000
1,124,000
1,022,000
1,623,000
1,841,000
1,719,000
1,789,000
1,756,000
1,630,000
1,444,000
1,427,000
1,582,000
1,785,000
1,605,000
1,738,000
1,580,000
1,786,000
1,605,000
1,702,000
1,895,000
1,929,000
1,813,000
1,844,000
4,059,000
3,474,000
3,310,000
3,272,000
3,386,000
3,094,000
3,128,000
3,483,000
3,396,000
3,172,000
3,579,000
3,833,000
4,055,000
3,981,000
4,099,000
4,245,000
4,218,000
4,450,000
4,450,0004,218,0004,245,0004,099,0003,981,0004,055,0003,833,0003,579,0003,172,0003,396,0003,483,0003,128,0003,094,0003,386,0003,272,0003,310,0003,474,0004,059,0001,844,0001,813,0001,929,0001,895,0001,702,0001,605,0001,786,0001,580,0001,738,0001,605,0001,785,0001,582,0001,427,0001,444,0001,630,0001,756,0001,789,0001,719,0001,841,0001,623,0001,022,0001,124,0001,008,0001,048,0001,104,0001,150,0001,172,0001,085,0001,037,0001,091,000958,878862,775915,794871,582000836,270
   > Long-term Assets 
0
0
0
0
12,303,011
12,210,515
11,716,594
11,799,240
11,654,000
12,246,000
12,248,000
11,709,000
11,350,000
11,328,000
11,251,000
10,899,000
11,459,000
11,291,000
36,978,000
36,920,000
36,736,000
37,098,000
50,420,000
50,336,000
49,912,000
50,117,000
50,032,000
49,910,000
49,563,000
48,898,000
47,796,000
47,699,000
42,407,000
42,356,000
42,042,000
39,275,000
39,596,000
39,441,000
128,274,000
126,612,000
126,392,000
123,932,000
121,973,000
119,901,000
118,601,000
116,702,000
114,086,000
110,961,000
110,342,000
108,056,000
106,515,000
102,997,000
101,709,000
110,003,000
108,121,000
115,637,000
115,637,000108,121,000110,003,000101,709,000102,997,000106,515,000108,056,000110,342,000110,961,000114,086,000116,702,000118,601,000119,901,000121,973,000123,932,000126,392,000126,612,000128,274,00039,441,00039,596,00039,275,00042,042,00042,356,00042,407,00047,699,00047,796,00048,898,00049,563,00049,910,00050,032,00050,117,00049,912,00050,336,00050,420,00037,098,00036,736,00036,920,00036,978,00011,291,00011,459,00010,899,00011,251,00011,328,00011,350,00011,709,00012,248,00012,246,00011,654,00011,799,24011,716,59412,210,51512,303,0110000
       Property Plant Equipment 
2,357,563
0
0
0
2,144,200
2,168,582
2,092,021
2,138,898
2,247,000
2,200,000
2,213,000
2,244,000
2,298,000
2,333,000
2,387,000
2,432,000
2,485,000
2,431,000
2,517,000
2,546,000
2,565,000
2,597,000
2,618,000
2,638,000
2,604,000
2,612,000
2,657,000
2,697,000
2,803,000
2,828,000
2,787,000
2,950,000
2,883,000
2,860,000
2,879,000
2,894,000
2,962,000
2,961,000
4,908,000
4,986,000
5,248,000
5,193,000
5,161,000
5,130,000
5,110,000
5,075,000
4,958,000
4,893,000
4,935,000
4,931,000
4,943,000
4,934,000
4,989,000
4,980,000
5,023,000
5,141,000
5,141,0005,023,0004,980,0004,989,0004,934,0004,943,0004,931,0004,935,0004,893,0004,958,0005,075,0005,110,0005,130,0005,161,0005,193,0005,248,0004,986,0004,908,0002,961,0002,962,0002,894,0002,879,0002,860,0002,883,0002,950,0002,787,0002,828,0002,803,0002,697,0002,657,0002,612,0002,604,0002,638,0002,618,0002,597,0002,565,0002,546,0002,517,0002,431,0002,485,0002,432,0002,387,0002,333,0002,298,0002,244,0002,213,0002,200,0002,247,0002,138,8982,092,0212,168,5822,144,2000002,357,563
       Goodwill 
6,197,182
0
0
0
6,099,652
6,164,149
5,973,558
6,092,202
6,130,000
6,060,000
6,120,000
6,199,000
6,277,000
6,271,000
6,244,000
6,002,000
5,862,000
5,534,000
13,209,000
13,243,000
13,168,000
13,274,000
15,507,000
15,657,000
15,416,000
15,490,000
15,652,000
15,748,000
15,785,000
15,880,000
15,692,000
15,718,000
15,663,000
15,606,000
15,642,000
15,537,000
15,604,000
15,561,000
42,669,000
42,801,000
33,124,000
32,349,000
32,398,000
32,296,000
32,379,000
32,298,000
32,028,000
31,726,000
32,156,000
32,220,000
32,224,000
32,091,000
32,293,000
33,426,000
33,386,000
35,295,000
35,295,00033,386,00033,426,00032,293,00032,091,00032,224,00032,220,00032,156,00031,726,00032,028,00032,298,00032,379,00032,296,00032,398,00032,349,00033,124,00042,801,00042,669,00015,561,00015,604,00015,537,00015,642,00015,606,00015,663,00015,718,00015,692,00015,880,00015,785,00015,748,00015,652,00015,490,00015,416,00015,657,00015,507,00013,274,00013,168,00013,243,00013,209,0005,534,0005,862,0006,002,0006,244,0006,271,0006,277,0006,199,0006,120,0006,060,0006,130,0006,092,2025,973,5586,164,1496,099,6520006,197,182
       Long Term Investments 
0
0
0
0
0
0
0
0
0
118,000
121,000
123,000
118,000
119,000
130,000
124,000
92,000
93,000
134,000
74,000
145,000
387,000
1,400,000
1,378,000
1,783,000
2,123,000
2,052,000
1,971,000
2,090,000
2,057,000
1,505,000
1,463,000
1,420,000
1,477,000
1,473,000
131,000
93,000
78,000
225,000
246,000
293,000
305,000
266,000
272,000
277,000
260,000
244,000
235,000
241,000
257,000
288,000
275,000
304,000
305,000
272,000
267,000
267,000272,000305,000304,000275,000288,000257,000241,000235,000244,000260,000277,000272,000266,000305,000293,000246,000225,00078,00093,000131,0001,473,0001,477,0001,420,0001,463,0001,505,0002,057,0002,090,0001,971,0002,052,0002,123,0001,783,0001,378,0001,400,000387,000145,00074,000134,00093,00092,000124,000130,000119,000118,000123,000121,000118,000000000000
       Intangible Assets 
9,888,360
0
0
0
2,910,167
2,744,549
2,540,297
2,431,057
2,323,000
2,153,000
2,101,000
1,993,000
1,890,000
1,802,000
1,695,000
1,540,000
1,513,000
1,478,000
19,937,000
19,822,000
19,709,000
19,512,000
29,450,000
29,113,000
28,897,000
28,629,000
28,366,000
28,167,000
27,559,000
27,230,000
26,903,000
26,625,000
21,233,000
20,846,000
20,459,000
19,036,000
18,649,000
18,203,000
76,463,000
74,643,000
82,876,000
81,293,000
79,340,000
77,456,000
75,951,000
73,986,000
71,823,000
68,725,000
67,439,000
64,848,000
62,862,000
58,603,000
55,610,000
62,225,000
60,243,000
66,646,000
66,646,00060,243,00062,225,00055,610,00058,603,00062,862,00064,848,00067,439,00068,725,00071,823,00073,986,00075,951,00077,456,00079,340,00081,293,00082,876,00074,643,00076,463,00018,203,00018,649,00019,036,00020,459,00020,846,00021,233,00026,625,00026,903,00027,230,00027,559,00028,167,00028,366,00028,629,00028,897,00029,113,00029,450,00019,512,00019,709,00019,822,00019,937,0001,478,0001,513,0001,540,0001,695,0001,802,0001,890,0001,993,0002,101,0002,153,0002,323,0002,431,0572,540,2972,744,5492,910,1670009,888,360
       Long-term Assets Other 
0
0
0
0
0
0
0
0
835,000
318,000
251,000
-269,000
767,000
-272,000
-309,000
277,000
611,000
699,000
-46,000
135,000
-4,127,000
-4,084,000
-5,735,000
-4,574,000
-5,678,000
-5,534,000
-5,086,000
-4,820,000
-1,164,000
-1,401,000
-761,000
-547,000
141,000
451,000
441,000
619,000
1,158,000
1,679,000
-776,000
-549,000
1,205,000
1,024,000
1,147,000
1,145,000
1,875,000
2,252,000
5,033,000
3,410,000
3,381,000
3,690,000
4,074,000
5,050,000
8,513,000
9,067,000
9,197,000
8,288,000
8,288,0009,197,0009,067,0008,513,0005,050,0004,074,0003,690,0003,381,0003,410,0005,033,0002,252,0001,875,0001,145,0001,147,0001,024,0001,205,000-549,000-776,0001,679,0001,158,000619,000441,000451,000141,000-547,000-761,000-1,401,000-1,164,000-4,820,000-5,086,000-5,534,000-5,678,000-4,574,000-5,735,000-4,084,000-4,127,000135,000-46,000699,000611,000277,000-309,000-272,000767,000-269,000251,000318,000835,00000000000
> Total Liabilities 
5,431,706
0
0
0
7,433,453
6,910,794
6,204,479
7,061,143
23,645,000
24,212,000
24,352,000
24,675,000
24,706,000
23,960,000
23,827,000
23,809,000
25,805,000
25,322,000
48,351,000
49,969,000
49,105,000
49,077,000
61,571,000
60,157,000
61,463,000
60,666,000
60,985,000
62,153,000
65,689,000
65,789,000
65,016,000
69,085,000
67,798,000
64,595,000
65,708,000
67,667,000
97,287,000
98,614,000
134,798,000
134,332,000
137,468,000
136,768,000
135,378,000
135,281,000
131,093,000
126,897,000
128,498,000
125,298,000
121,518,000
121,241,000
122,469,000
124,092,000
124,314,000
140,827,000
135,116,000
137,351,000
137,351,000135,116,000140,827,000124,314,000124,092,000122,469,000121,241,000121,518,000125,298,000128,498,000126,897,000131,093,000135,281,000135,378,000136,768,000137,468,000134,332,000134,798,00098,614,00097,287,00067,667,00065,708,00064,595,00067,798,00069,085,00065,016,00065,789,00065,689,00062,153,00060,985,00060,666,00061,463,00060,157,00061,571,00049,077,00049,105,00049,969,00048,351,00025,322,00025,805,00023,809,00023,827,00023,960,00024,706,00024,675,00024,352,00024,212,00023,645,0007,061,1436,204,4796,910,7947,433,4530005,431,706
   > Total Current Liabilities 
3,761,248
0
0
0
5,896,678
5,514,959
4,839,721
5,367,892
6,776,000
6,766,000
6,805,000
6,875,000
6,879,000
6,216,000
6,317,000
6,635,000
11,400,000
11,050,000
11,258,000
8,813,000
10,894,000
10,662,000
9,272,000
9,103,000
9,781,000
8,844,000
12,259,000
13,033,000
16,641,000
17,058,000
17,224,000
15,387,000
17,239,000
13,904,000
16,941,000
17,493,000
15,585,000
16,471,000
24,646,000
24,181,000
28,661,000
31,951,000
28,684,000
28,533,000
35,194,000
32,521,000
34,473,000
32,712,000
29,538,000
27,590,000
32,239,000
34,773,000
37,841,000
41,522,000
41,915,000
43,062,000
43,062,00041,915,00041,522,00037,841,00034,773,00032,239,00027,590,00029,538,00032,712,00034,473,00032,521,00035,194,00028,533,00028,684,00031,951,00028,661,00024,181,00024,646,00016,471,00015,585,00017,493,00016,941,00013,904,00017,239,00015,387,00017,224,00017,058,00016,641,00013,033,00012,259,0008,844,0009,781,0009,103,0009,272,00010,662,00010,894,0008,813,00011,258,00011,050,00011,400,0006,635,0006,317,0006,216,0006,879,0006,875,0006,805,0006,766,0006,776,0005,367,8924,839,7215,514,9595,896,6780003,761,248
       Short-term Debt 
0
0
0
0
0
0
0
0
1,042,000
436,000
432,000
434,000
431,000
20,000
271,000
323,000
4,446,000
4,590,000
4,007,000
768,000
2,431,000
2,423,000
517,000
26,000
402,000
425,000
3,420,000
3,821,000
6,415,000
6,381,000
6,530,000
4,021,000
5,308,000
2,078,000
5,641,000
5,276,000
3,753,000
3,762,000
5,371,000
4,777,000
8,502,000
11,347,000
7,901,000
6,672,000
12,495,000
9,952,000
11,930,000
9,207,000
4,136,000
2,801,000
5,203,000
5,115,000
7,191,000
10,196,000
12,586,000
12,570,000
12,570,00012,586,00010,196,0007,191,0005,115,0005,203,0002,801,0004,136,0009,207,00011,930,0009,952,00012,495,0006,672,0007,901,00011,347,0008,502,0004,777,0005,371,0003,762,0003,753,0005,276,0005,641,0002,078,0005,308,0004,021,0006,530,0006,381,0006,415,0003,821,0003,420,000425,000402,00026,000517,0002,423,0002,431,000768,0004,007,0004,590,0004,446,000323,000271,00020,000431,000434,000432,000436,0001,042,00000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,014,000
0
0
0
2,025,000
2,423,000
517,000
26,000
25,000
425,000
37,543,000
3,021,000
6,015,000
6,024,000
3,026,000
1,026,000
1,609,000
2,078,000
5,641,000
5,276,000
3,753,000
3,762,000
5,371,000
4,777,000
8,502,000
11,347,000
7,901,000
6,672,000
12,495,000
9,952,000
11,930,000
9,207,000
4,136,000
2,801,000
5,203,000
5,115,000
7,191,000
10,196,000
12,586,000
12,570,000
12,570,00012,586,00010,196,0007,191,0005,115,0005,203,0002,801,0004,136,0009,207,00011,930,0009,952,00012,495,0006,672,0007,901,00011,347,0008,502,0004,777,0005,371,0003,762,0003,753,0005,276,0005,641,0002,078,0001,609,0001,026,0003,026,0006,024,0006,015,0003,021,00037,543,000425,00025,00026,000517,0002,423,0002,025,0000004,014,0000000000000000000
       Accounts payable 
356,784
0
0
0
417,030
476,129
337,118
423,907
556,000
6,330,000
6,373,000
6,441,000
933,000
6,196,000
6,046,000
6,312,000
881,000
6,460,000
7,251,000
8,045,000
1,597,000
8,239,000
8,755,000
9,077,000
1,407,000
8,419,000
8,839,000
9,212,000
1,474,000
10,677,000
10,694,000
11,366,000
1,546,000
11,826,000
11,300,000
12,217,000
1,452,000
12,709,000
19,275,000
19,404,000
2,276,000
20,604,000
20,200,000
21,861,000
2,882,000
22,569,000
22,108,000
23,389,000
2,934,000
24,654,000
26,905,000
29,570,000
3,688,000
31,258,000
29,296,000
30,398,000
30,398,00029,296,00031,258,0003,688,00029,570,00026,905,00024,654,0002,934,00023,389,00022,108,00022,569,0002,882,00021,861,00020,200,00020,604,0002,276,00019,404,00019,275,00012,709,0001,452,00012,217,00011,300,00011,826,0001,546,00011,366,00010,694,00010,677,0001,474,0009,212,0008,839,0008,419,0001,407,0009,077,0008,755,0008,239,0001,597,0008,045,0007,251,0006,460,000881,0006,312,0006,046,0006,196,000933,0006,441,0006,373,0006,330,000556,000423,907337,118476,129417,030000356,784
       Other Current Liabilities 
3,404,464
0
0
0
5,479,648
5,038,830
4,502,603
4,943,985
5,178,000
6,330,000
6,373,000
6,441,000
5,515,000
6,196,000
6,046,000
6,312,000
6,073,000
6,460,000
7,251,000
8,045,000
6,866,000
8,239,000
8,755,000
9,077,000
7,972,000
8,419,000
8,839,000
9,212,000
8,752,000
10,677,000
10,694,000
11,366,000
10,385,000
11,826,000
11,300,000
12,217,000
10,380,000
12,709,000
19,275,000
19,404,000
17,883,000
20,604,000
20,783,000
21,861,000
19,817,000
22,569,000
435,000
-1,856,000
22,468,000
24,789,000
27,036,000
29,658,000
26,962,000
31,326,000
29,329,000
30,492,000
30,492,00029,329,00031,326,00026,962,00029,658,00027,036,00024,789,00022,468,000-1,856,000435,00022,569,00019,817,00021,861,00020,783,00020,604,00017,883,00019,404,00019,275,00012,709,00010,380,00012,217,00011,300,00011,826,00010,385,00011,366,00010,694,00010,677,0008,752,0009,212,0008,839,0008,419,0007,972,0009,077,0008,755,0008,239,0006,866,0008,045,0007,251,0006,460,0006,073,0006,312,0006,046,0006,196,0005,515,0006,441,0006,373,0006,330,0005,178,0004,943,9854,502,6035,038,8305,479,6480003,404,464
   > Long-term Liabilities 
0
0
0
0
1,536,775
1,395,835
1,364,758
1,693,251
16,869,000
17,446,000
17,547,000
17,800,000
17,827,000
17,744,000
17,510,000
17,174,000
14,405,000
14,272,000
37,093,000
41,156,000
38,211,000
38,415,000
52,299,000
51,054,000
51,682,000
51,822,000
48,726,000
49,120,000
49,048,000
48,731,000
47,792,000
53,698,000
50,559,000
50,691,000
48,767,000
50,174,000
81,702,000
82,143,000
110,152,000
110,151,000
108,807,000
104,817,000
106,694,000
106,748,000
95,899,000
94,376,000
94,025,000
92,586,000
91,980,000
93,651,000
90,230,000
89,319,000
86,473,000
99,305,000
93,201,000
94,289,000
94,289,00093,201,00099,305,00086,473,00089,319,00090,230,00093,651,00091,980,00092,586,00094,025,00094,376,00095,899,000106,748,000106,694,000104,817,000108,807,000110,151,000110,152,00082,143,00081,702,00050,174,00048,767,00050,691,00050,559,00053,698,00047,792,00048,731,00049,048,00049,120,00048,726,00051,822,00051,682,00051,054,00052,299,00038,415,00038,211,00041,156,00037,093,00014,272,00014,405,00017,174,00017,510,00017,744,00017,827,00017,800,00017,547,00017,446,00016,869,0001,693,2511,364,7581,395,8351,536,7750000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
14,601,000
14,326,000
14,375,000
14,292,000
14,386,000
14,470,000
14,469,000
10,565,000
10,683,000
27,116,000
31,359,000
29,240,000
29,490,000
37,328,000
37,284,000
36,440,000
36,526,000
33,817,000
33,974,000
30,953,000
30,906,000
30,579,000
36,487,000
35,002,000
35,066,000
31,619,000
33,126,000
62,975,000
63,284,000
82,061,000
82,282,000
77,554,000
74,183,000
74,237,000
74,049,000
64,189,000
63,522,000
61,002,000
60,399,000
59,135,000
59,292,000
55,812,000
0
0
0
0
0
0000055,812,00059,292,00059,135,00060,399,00061,002,00063,522,00064,189,00074,049,00074,237,00074,183,00077,554,00082,282,00082,061,00063,284,00062,975,00033,126,00031,619,00035,066,00035,002,00036,487,00030,579,00030,906,00030,953,00033,974,00033,817,00036,526,00036,440,00037,284,00037,328,00029,490,00029,240,00031,359,00027,116,00010,683,00010,565,00014,469,00014,470,00014,386,00014,292,00014,375,00014,326,00014,601,000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
2,845,000
3,221,000
3,425,000
3,535,000
3,358,000
3,040,000
2,705,000
3,840,000
3,589,000
3,918,000
3,801,000
3,695,000
3,513,000
7,791,000
7,646,000
8,352,000
8,499,000
8,518,000
8,999,000
15,605,000
15,521,000
15,543,000
15,721,000
14,490,000
14,509,000
16,000,000
15,990,000
17,597,000
17,900,000
23,306,000
23,384,000
27,607,000
26,866,000
28,796,000
29,097,000
28,701,000
28,023,000
30,768,000
30,215,000
30,655,000
32,249,000
32,294,000
31,644,000
28,607,000
32,778,000
32,427,000
33,031,000
33,031,00032,427,00032,778,00028,607,00031,644,00032,294,00032,249,00030,655,00030,215,00030,768,00028,023,00028,701,00029,097,00028,796,00026,866,00027,607,00023,384,00023,306,00017,900,00017,597,00015,990,00016,000,00014,509,00014,490,00015,721,00015,543,00015,521,00015,605,0008,999,0008,518,0008,499,0008,352,0007,646,0007,791,0003,513,0003,695,0003,801,0003,918,0003,589,0003,840,0002,705,0003,040,0003,358,0003,535,0003,425,0003,221,0002,845,000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,059,000
5,996,000
5,276,000
5,412,000
7,180,000
6,124,000
6,890,000
6,797,000
6,391,000
6,147,000
2,490,000
2,304,000
1,670,000
1,490,000
1,067,000
1,116,000
1,148,000
1,058,000
1,130,000
959,000
4,785,000
4,485,000
3,646,000
3,768,000
3,661,000
3,602,000
3,009,000
2,831,000
2,255,000
1,972,000
2,190,000
2,110,000
2,124,000
0
0
0
0
0
000002,124,0002,110,0002,190,0001,972,0002,255,0002,831,0003,009,0003,602,0003,661,0003,768,0003,646,0004,485,0004,785,000959,0001,130,0001,058,0001,148,0001,116,0001,067,0001,490,0001,670,0002,304,0002,490,0006,147,0006,391,0006,797,0006,890,0006,124,0007,180,0005,412,0005,276,0005,996,0006,059,000000000000000000000
> Total Stockholder Equity
15,702,999
0
0
0
12,223,713
12,050,769
11,505,075
15,668,836
3,363,000
2,957,000
3,558,000
3,577,000
4,492,000
4,697,000
5,218,000
4,645,000
1,742,000
1,377,000
5,504,000
4,863,000
3,945,000
4,643,000
5,640,000
6,469,000
4,636,000
4,998,000
6,009,000
6,687,000
5,097,000
3,553,000
-3,375,000
-2,921,000
-8,446,000
-7,826,000
-8,566,000
-8,226,000
-8,172,000
-7,415,000
14,708,000
15,270,000
13,076,000
13,710,000
12,569,000
13,550,000
15,408,000
16,283,000
14,653,000
15,994,000
17,254,000
13,274,000
12,866,000
12,094,000
10,360,000
8,007,000
6,778,000
6,032,000
6,032,0006,778,0008,007,00010,360,00012,094,00012,866,00013,274,00017,254,00015,994,00014,653,00016,283,00015,408,00013,550,00012,569,00013,710,00013,076,00015,270,00014,708,000-7,415,000-8,172,000-8,226,000-8,566,000-7,826,000-8,446,000-2,921,000-3,375,0003,553,0005,097,0006,687,0006,009,0004,998,0004,636,0006,469,0005,640,0004,643,0003,945,0004,863,0005,504,0001,377,0001,742,0004,645,0005,218,0004,697,0004,492,0003,577,0003,558,0002,957,0003,363,00015,668,83611,505,07512,050,76912,223,71300015,702,999
   Common Stock
0
0
0
0
0
0
0
0
3,713,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
17,000
17,000
17,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,000
18,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00018,00017,00017,00017,00016,00016,00016,00016,00016,00016,00016,00016,00016,0003,713,00000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
330,000
758,000
1,081,000
1,567,000
1,874,000
2,299,000
2,131,000
535,000
739,000
1,256,000
1,654,000
2,248,000
2,673,000
3,349,000
4,011,000
4,378,000
5,063,000
5,951,000
6,547,000
5,459,000
4,977,000
5,495,000
6,789,000
3,368,000
4,234,000
3,384,000
3,673,000
4,717,000
5,973,000
3,130,000
3,335,000
1,055,000
2,292,000
740,000
1,600,000
3,127,000
5,103,000
3,516,000
4,953,000
4,784,000
2,393,000
1,789,000
0
0
0
0
0
000001,789,0002,393,0004,784,0004,953,0003,516,0005,103,0003,127,0001,600,000740,0002,292,0001,055,0003,335,0003,130,0005,973,0004,717,0003,673,0003,384,0004,234,0003,368,0006,789,0005,495,0004,977,0005,459,0006,547,0005,951,0005,063,0004,378,0004,011,0003,349,0002,673,0002,248,0001,654,0001,256,000739,000535,0002,131,0002,299,0001,874,0001,567,0001,081,000758,000330,000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-25,166
194,180
-325,493
-164,918
-350,000
-1,237,000
-1,169,000
-981,000
-442,000
-426,000
-420,000
-913,000
-2,031,000
-2,467,000
-2,374,000
-2,499,000
-2,561,000
-2,423,000
-2,390,000
-2,340,000
-2,586,000
-2,542,000
-2,548,000
-2,613,000
-2,727,000
-2,630,000
-2,639,000
-2,559,000
-2,480,000
-2,516,000
-2,491,000
-2,528,000
-3,596,000
-3,697,000
-3,435,000
-3,259,000
-3,117,000
-3,295,000
-3,103,000
-3,156,000
-2,899,000
-2,984,000
-3,196,000
-3,443,000
-2,199,000
-2,232,000
-2,252,000
-2,353,000
-2,305,000
-2,454,000
-2,513,000
-2,334,000
-2,334,000-2,513,000-2,454,000-2,305,000-2,353,000-2,252,000-2,232,000-2,199,000-3,443,000-3,196,000-2,984,000-2,899,000-3,156,000-3,103,000-3,295,000-3,117,000-3,259,000-3,435,000-3,697,000-3,596,000-2,528,000-2,491,000-2,516,000-2,480,000-2,559,000-2,639,000-2,630,000-2,727,000-2,613,000-2,548,000-2,542,000-2,586,000-2,340,000-2,390,000-2,423,000-2,561,000-2,499,000-2,374,000-2,467,000-2,031,000-913,000-420,000-426,000-442,000-981,000-1,169,000-1,237,000-350,000-164,918-325,493194,180-25,1660000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
3,945,000
4,074,000
3,580,000
3,671,000
3,905,000
3,996,000
4,083,000
4,194,000
4,403,000
12,421,000
13,005,000
13,080,000
13,293,000
13,046,000
13,540,000
13,678,000
13,889,000
14,015,000
14,154,000
14,270,000
14,519,000
14,596,000
14,680,000
14,756,000
14,940,000
15,028,000
15,112,000
15,193,000
15,401,000
16,953,000
17,148,000
17,384,000
17,712,000
17,936,000
18,108,000
18,305,000
18,731,000
18,906,000
19,056,000
19,245,000
19,619,000
19,839,000
0
0
0
0
0
0000019,839,00019,619,00019,245,00019,056,00018,906,00018,731,00018,305,00018,108,00017,936,00017,712,00017,384,00017,148,00016,953,00015,401,00015,193,00015,112,00015,028,00014,940,00014,756,00014,680,00014,596,00014,519,00014,270,00014,154,00014,015,00013,889,00013,678,00013,540,00013,046,00013,293,00013,080,00013,005,00012,421,0004,403,0004,194,0004,083,0003,996,0003,905,0003,671,0003,580,0004,074,0003,945,000000000000
   Treasury Stock000-6,533,000-6,525,000-6,528,000-6,524,000-4,594,000-4,590,000-4,591,000-4,585,000-3,143,000-3,020,000-3,022,000-3,017,000-2,264,000-1,972,000-1,958,000-25,110,000-24,504,000-24,501,000-24,505,000-24,502,000-24,108,000-21,849,000-20,845,000-13,331,000-11,923,000-11,419,000-11,427,000-11,430,000-10,852,000-8,760,000-8,383,000-8,918,000-8,839,000-7,314,000-5,816,000-1,314,000-972,000-672,000-673,000-672,000-320,000-119,000-121,000-97,000000000000
   Other Stockholders Equity 
0
0
0
0
12,248,879
11,856,589
11,830,568
15,833,754
0
3,848,000
3,953,000
3,461,000
3,351,000
3,233,000
3,323,000
3,411,000
3,222,000
3,089,000
6,605,000
5,691,000
4,241,000
4,375,000
4,663,000
4,780,000
2,826,000
2,459,000
2,588,000
2,735,000
2,347,000
1,188,000
-6,249,000
-7,169,000
-9,352,000
-9,562,000
-9,477,000
-9,389,000
-9,311,000
-9,709,000
14,995,000
15,176,000
15,120,000
14,695,000
14,914,000
15,088,000
15,162,000
14,146,000
14,315,000
14,466,000
14,651,000
13,095,000
13,311,000
13,496,000
13,647,000
12,827,000
13,041,000
13,312,000
13,312,00013,041,00012,827,00013,647,00013,496,00013,311,00013,095,00014,651,00014,466,00014,315,00014,146,00015,162,00015,088,00014,914,00014,695,00015,120,00015,176,00014,995,000-9,709,000-9,311,000-9,389,000-9,477,000-9,562,000-9,352,000-7,169,000-6,249,0001,188,0002,347,0002,735,0002,588,0002,459,0002,826,0004,780,0004,663,0004,375,0004,241,0005,691,0006,605,0003,089,0003,222,0003,411,0003,323,0003,233,0003,351,0003,461,0003,953,0003,848,000015,833,75411,830,56811,856,58912,248,8790000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.